Evidence map›Paper›PMID 32377982›Full record

ArticleApplied health economics and health policy2020

Impact of a Global Pandemic on Health Technology Assessment.

Paula K Lorgelly, Amanda Adler

Abstract read
In one paragraph

Article in Applied health economics and health policy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Impact of COVID-19 pandemic on HTAsiaLink network members.International journal of technology assessment in health care · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2020
    Article
  12. Monitoring Information Flow on Coronavirus Disease 2019 (COVID-19).Mediterranean journal of rheumatology · 2020
    Article
  13. Impact of COVID-19 pandemic on HTA.PharmacoEconomics & outcomes news · 2020
    Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Paula K LorgellyDepartment of Applied Health Research, University College London, 1-19 Torrington Place, London, WC1E 7HB, UK. p.lorgelly@ucl.ac.uk.ORCID http://orcid.org/0000-0002-8990-9514
Amanda AdlerDiabetes Trial Unit, University of Oxford, Oxford, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Global HealthPandemicsTechnology Assessment, BiomedicalClinical Trials as TopicCOVID-19 Drug TreatmentHumansResearchSARS-CoV-2

Identifiers

PMID32377982
PMCPMC7202921

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.